Striatal D - Compound Card

Striatal D

Select a section from the left sidebar

Striatal D

Structure
Zoomed Structure
  • Family: Fungi - Hericiaceae
  • Kingdom: Fungi
  • Class: Terpenoid
    • Subclass: Cyathane Diterpenoid
Canonical Smiles O=CC1=CC[C@H]2[C@@]([C@@H]3[C@@H]1[C@]1(O)[C@H](O3)OC[C@H](C1=O)O)(C)CC[C@@]1(C2=C(CC1)C(C)C)C
InChI InChI=1S/C25H34O6/c1-13(2)15-7-8-23(3)9-10-24(4)16(19(15)23)6-5-14(11-26)18-21(24)31-22-25(18,29)20(28)17(27)12-30-22/h5,11,13,16-18,21-22,27,29H,6-10,12H2,1-4H3/t16-,17-,18-,21+,22+,23-,24-,25-/m1/s1
InChIKey REGAUEHONPNYTR-VFWOXKFUSA-N
Formula C25H34O6
HBA 6
HBD 2
MW 430.54
Rotatable Bonds 2
TPSA 93.06
LogP 2.72
Number Rings 5
Number Aromatic Rings 0
Heavy Atom Count 31
Formal Charge 0
Fraction CSP3 0.76
Exact Mass 430.24
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Laxitextum incrustatum Hericiaceae Fungi 1812024

Showing of synonyms

  • Mudalungu CM, Richter C, et al. (2016). Laxitextines A and B, Cyathane Xylosides from the Tropical Fungus Laxitextum incrustatum.. Journal of Natural Products,2016,22,79(4),894-898. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCC(C=12)CCC3C4C(C=CCC23)C5C(O4)OCCC5=O

Level: 0

Mol. Weight: 430.54 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.74
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.75
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-1.9

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.81
Plasma Protein Binding
62.11
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
11.27
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-1.17
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.07
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
7.44
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Toxic
T. Pyriformis
-58.58
Rat (Acute)
5.18
Rat (Chronic Oral)
1.99
Fathead Minnow
4.02
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Toxic
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
437.82
Hydration Free Energy
-3.12
Log(D) at pH=7.4
3.22
Log(P)
3.8
Log S
-3.97
Log(Vapor Pressure)
-8.69
Melting Point
206.08
pKa Acid
5.6
pKa Basic
4.03
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7538
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7538

Download SDF